Alnylam Pharmaceuticals
MA · 3 filings, 2025
Lobbying spend · 2025
$140K
to shape legislation
Its PAC gave
$20K
◆ Alnylam PAC → 2 lawmakers
About the organization
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. via Wikipedia ↗
1Lobbies on
Its filings list: Medicare/Medicaid
2Through these firms · 1
THE MCMANUS GROUP
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews
4And its PAC funds these lawmakers · 2
Democrats · 0$0
No democrats on file.
Republicans · 2$20,000